CN Patent

CN102906093A — 新型nk-3受体选择性拮抗剂化合物、药物组合物以及在nk-3受体介导的疾病中的使用方法

Assigned to Oge Of Ltd Co · Expires 2013-01-30 · 13y expired

What this patent protects

本发明涉及式I的新型化合物 和它们作为治疗性化合物的用途。

USPTO Abstract

本发明涉及式I的新型化合物 和它们作为治疗性化合物的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN102906093A
Jurisdiction
CN
Classification
—
Expires
2013-01-30
Drug substance claim
No
Drug product claim
No
Assignee
Oge Of Ltd Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.